Journal of surgical case reports
Chemotherapy-induced secondary sclerosing cholangitis mimicking primary sclerosing cholangitis: a case report
By Demirhan N and Çağlayan K.
Abstract
Secondary sclerosing cholangitis (SSC) is a rare condition that may mimic primary sclerosing cholangitis. Chemotherapy-related biliary injury is an emerging cause. We present a 72-year-old male with gastric carcinoma who developed cholestatic liver injury following oxaliplatin-based chemotherapy. Imaging revealed intrahepatic biliary dilatation without an obstructing lesion. Percutaneous transhepatic cholangiography confirmed biliary abnormalities. The patient was managed with biliary drainage and supportive care, resulting in gradual clinical and biochemical improvement. Chemotherapy-induced SSC should be considered in patients with cholestatic liver injury after oxaliplatin-based regimens, and early recognition is essential.
Keywords
- bile duct injury
- chemotherapy
- hepatotoxicity
- oxaliplatin
- secondary sclerosing cholangitis
Source
Published in Journal of surgical case reports. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
More in oncology
- The value of breast brachytherapy boost in the current era: a narrative literature review from the GEC-ESTRO breast cancer working groupClinical and Translational Radiation Oncology · 2026
- Academic treatment optimization studies in oncology and internal medicine: a risk- and burden-adapted regulatory framework for the European UnionThe Lancet Regional Health. Europe · 2026
